Celator Pharmaceuticals, Inc.

États‑Unis d’Amérique


Commandez votre montre hebdomadaire Celator Pharmaceuticals, Inc.
Quantité totale PI 36
Rang # Quantité totale PI 40 382
Note d'activité PI 2/5.0    12
Rang # Activité PI 72 813
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

4 0
13 6
13 0
0
 
Dernier brevet 2025 - Methods of use of a liposomal co...
Premier brevet 2002 - Compositions for delivery of dru...
Dernière marque 2015 - VYXEOS
Première marque 2000 - CELATOR

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Methods of use of a liposomal composition comprising an atr inhibitor. The present disclosure gen...
2023 Invention Inhibiting ataxia telangiectasia and rad3-related protein (atr). Novel compounds inhibiting ATR ...
2022 Invention Nanoparticle delivery systems. Nanoparticle compositions described herein comprise combinations ...
Invention Liposomal formulations of bcl inhibitors. Provided herein are liposomes comprising B-cell lymphom...
Invention Methods for preparing liposomal formulations. Provided herein are methods of purifying liposomal ...
2020 Invention Method of lyophilizing liposomes. Lyophilized liposomal formulations with two or more encapsulat...
2019 Invention Combination formulations of taxanes and mtor inhibitors. The invention relates to compositions an...
Invention Low-intensity treatment of hematological disorders. The invention relates to compositions and me...
Invention Low-intensity treatment of hematological disorders. The invention relates to compositions and met...
2018 Invention Compositions for delivery of drug combinations. Compositions which comprise delivery vehicles hav...
Invention Combination methods and compositions. Compositions which comprise a liposomal camptothecin and o...
Invention Particulate constructs for release of active agents. Particulate constructs stabilized by amphip...
2016 Invention Assays and methods for selecting a treatment regimen for a subject with leukemia. Diagnostic meth...
Invention Improved nanoparticle delivery systems. Nanopaiticle compositions described herein comprise combi...
2015 Invention Platinum drug formulations. Compositions which comprise liposomes having controlled release of a...
P/S Pharmaceutical preparations for the treatment of cancer.
P/S Pharmaceutical preparations for the treatment of cancer
2012 Invention Lyophilized liposomes. Lyophilized liposomal formulations with two or more encapsulated drugs are...
2010 Invention Lipid carrier compositions with enhanced blood stability. Liposomes that contain at least 10 mol...
2009 Invention Combination methods and compositions. Compositions which comprise a liposomal water-soluble camp...
2008 Invention Taxane delivery system. Nanoparticulate formulations for delivery of taxane conjugate prodrug for...
Invention Improved taxane delivery system. Nanoparticulate formulations for delivery of taxane conjugate pr...
Invention Fixed ratio camptothecens/platinum agents. Compositions which comprise liposomes having controll...
Invention Improved platinum drug formulations. Compositions which comprise liposomes having controlled rele...
Invention Fixed drug ratios for treatment of hematopoietic cancers and proliferative disorders. Provided he...
2007 Invention Compositions for delivery of drug combinations. Compositions which comprise delivery vehicles ha...
Invention Compositions for delivery of drug combinations. Methods to prepare compositions which comprise d...
2006 Invention Liposomal formulations comprising secondary and tertiary amines and methods for preparing thereof...
Invention Localized delivery of drug combinations. Implants comprising controlled delivery matrices, assoc...
Invention Localized delivery of drug combinations. Implants comprising controlled delivery matrices, associ...
Invention Fixed ratio drug combination treatments for solid tumors. Provided herein are methods for treati...
Invention Fixed ratio drug combination treatments for solid tumors. Provided herein are methods for treatin...
Invention Combination formulations of cytidine analogs and platinum agents. Compositions which comprise de...
Invention Combination formulations of cytidine analogs and platinum agents. Compositions which comprise del...
Invention Lipid carrier compositions with reduced polydispersity. The invention relates to a method for red...
2005 Invention Method for loading multiple agents into delivery vehicles. This invention relates to encapsulati...
Invention Method for loading multiple agents into delivery vehicles. This invention relates to encapsulatio...
Invention Liposome loading with metal ions. This invention relates to encapsulation of drugs and other age...
P/S Pharmaceutical and medicinal preparations for the treatment of cancer, wound healing, cardiovascu...
P/S Research and development services for the development of diagonstic and therapeutic agents for di...
Invention Partuculate constructs for release of active agents. Particulate constructs stabilized by amphiph...
Invention Liposomal formulations of anthracycline agents and cytidine analogs. Compositions which comprise ...
2004 Invention Combination compositions of camptothecins and fluoropyrimidines. Compositions which comprise lip...
Invention Methods to individualize combination therapy. Compositions which comprise delivery vehicles havi...
Invention Compositions for treating drug resistance. Delivery vehicle compositions having stably associate...
Invention Pharmaceutical compositions containing active agents having a lactone group and transition metal ...
Invention Enhanced delivery of sphingolipids. Compositions which comprise delivery vehicles having stably ...
2003 P/S Research and development services for the development of diagnostic and therapeutic agents for di...
2002 Invention Polymer-lipid delivery vehicles. Delivery vehicles comprising nanoparticles which are composed o...
Invention Lipid carrier compositions and methods for improved drug retention. Liposomal compositions which...